Adalimumab in Treating Refractory Livedoid Vasculopathy

Livedoid vasculopathy is a chronic, recurrent skin disorder. It seriously affects the quality of patients’ life. However, the pathogenesis has not been fully identified yet. Here, this retrospective study describes the successful use of anti-TNF-α agent adalimumab in three cases of refractory livedo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiao-Wen, Zheng, Huan-Xin, Wang, Meng-Lei, He, Wan-Mei, Feng, Mei-Xin, Zeng, Kang, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026708/
https://www.ncbi.nlm.nih.gov/pubmed/35455298
http://dx.doi.org/10.3390/vaccines10040549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026708/
https://www.ncbi.nlm.nih.gov/pubmed/35455298
http://dx.doi.org/10.3390/vaccines10040549

Ejemplares similares